Drug Resistance, Epigenetics, and Tumor Cell Heterogeneity-Reference-Cited by-同舟云学术

Drug Resistance, Epigenetics, and Tumor Cell Heterogeneity

Published:2010-04-21 Issue:28 Volume:2 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Hoey Timothy¹

Affiliation:

1. OncoMed Pharmaceuticals, Redwood City, CA 94063, USA.

Abstract

Acquisition of drug resistance can occur through changes at the chromatin level in subpopulations of cancer cells and thus is linked to heterogeneity within tumors.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference13 articles.

1. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

2. Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance

3. The Increasing Complexity of the Cancer Stem Cell Paradigm

4. Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis

5. RBP2 Belongs to a Family of Demethylases, Specific for Tri-and Dimethylated Lysine 4 on Histone 3

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-cancer landscape of epigenetic factor expression predicts tumor outcome;Communications Biology;2023-11-16

2. A novel chromatin regulator signature predicts the prognosis, clinical features and immunotherapy of colon cancer;Epigenomics;2022-11

3. Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy;Acta Pharmaceutica Sinica B;2022-11

4. Epigenetic tumor heterogeneity in the era of single-cell profiling with nanopore sequencing;Clinical Epigenetics;2022-08-27

5. Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization;Oncogene;2021-03-25